Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP

被引：3
|
作者：
Adams, Hugo J. A. [1 ]
Kwee, Thomas C. [2 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol Nucl Med & Mol Imaging, Groningen, Netherlands
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 185卷 / 04期
关键词：
FDG-PET; Hodgkin lymphoma; POSITRON-EMISSION-TOMOGRAPHY;
D O I：
10.1111/bjh.15602
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：758 / 760
页数：3
相关论文
共 50 条
  • [31] Predicting outcomes after a positive interim FDG-PET scan in advanced Hodgkin's lymphoma
    Crump, Michael
    LANCET ONCOLOGY, 2017, 18 (04): : 416 - 418
  • [32] Early detection of chemotherapy resistance in negative interim FDG-PET Hodgkin lymphoma patients
    Cerci, Juliano
    Zanoni, Lucia
    Shah, Chirayu
    Chiti, Arturo
    Lee, Sze Ting
    Meneghetti, Jose
    Hutchings, Martin
    Biggi, Alberto
    Delbeke, Dominique
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [33] Predictive role of Early Interim FDG-PET in Hodgkin Lymphoma.
    Stefoni, Vittorio
    Broccoli, Alessandro
    Alinari, Lapo
    Ambrosini, Valentina
    Derenzini, Enrico
    Fanti, Stefano
    Fina, Mariapaola
    Gandolfi, Letizia
    Marchi, Enrica
    Pellegrini, Cinzia
    Quirini, Federica
    Zinzani, Pier Luigi
    Baccarani, Michele
    BLOOD, 2009, 114 (22) : 662 - 662
  • [34] Treatment outcome in patients with advanced-stage Hodgkin's lymphoma after developing drug intolerance to components of ABVD or BEACOPP regimens
    Bogatyreva, T.
    Kravtchenko, T.
    Strelnikova, E.
    Nestaiko, T.
    EJC SUPPLEMENTS, 2007, 5 (04): : 352 - 352
  • [35] Treatment Reduction in Patients with Advanced-Stage Hodgkin Lymphoma and Negative Interim FDG-PET: Final Results of the International, Randomized, Phase 3 HD18 Trial by the German Hodgkin Study Group
    Kobe, C.
    Goergen, H.
    Fuchs, M.
    Eich, H. T.
    Baues, C.
    Diehl, V.
    Kuhnert, G.
    Drzezga, A.
    Dietlein, M.
    Engert, A.
    Borchmann, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S312 - S312
  • [36] The use of FDG-PET to guide consolidative radiotherapy in patients with advanced-stage Hodgkin lymphoma with residual abnormalities on CT scan following ABVD chemotherapy
    Savage, K. J.
    Connors, J. M.
    Klasa, R. J.
    Hoskins, P.
    Shenkier, T. N.
    Gascoyne, R. D.
    Bhimji, S.
    Pickles, T.
    Benard, F.
    Wilson, D.
    Sehn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma
    Niitsu, Nozomi
    Okamoto, Masataka
    Tomita, Naoto
    Aoki, Sadao
    Tamaru, Jun-ichi
    Miura, Ikuo
    Hirano, Masami
    LEUKEMIA & LYMPHOMA, 2006, 47 (09) : 1908 - 1914
  • [38] Prognostic value of massiveness parameters measured on baseline FDG PET in advanced-stage Hodgkin lymphoma
    Draye-Carbonnier, S.
    Mihailescu, S.
    Pinochet, P.
    Texte, E.
    Stamatoullas-Bastard, A.
    Vera, P.
    Becker, S.
    Decazes, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S575 - S575
  • [39] Early Interim PET in Patients with Advanced-Stage Hodgkin's Lymphoma Treated within the Phase 3 GHSG HD18 Study
    Borchmann, Peter
    Goergen, Helen
    Kobe, Carsten
    Lohri, Andreas
    Greil, Richard
    Eichenauer, Dennis A.
    Zijlstra, Josee M.
    Markova, Jana
    Meissner, Julia
    Feuring-Buske, Michaela
    Huttmann, Andreas
    Dierlamm, Judith
    Sokler, Martin
    Krause, Stefan W.
    Eich, Hans
    Baues, Christian
    Kreissl, Stefanie
    Fuchs, Michael
    Dietlein, Markus
    Engert, Andreas
    BLOOD, 2017, 130
  • [40] Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP
    Ron D. Jachimowicz
    Wolfram Klapper
    Gunther Glehr
    Horst Müller
    Heinz Haverkamp
    Christoph Thorns
    Martin Leo Hansmann
    Peter Möller
    Harald Stein
    Thorsten Rehberg
    Bastian von Tresckow
    H. C. Reinhardt
    Peter Borchmann
    Fong Chun Chan
    Rainer Spang
    David W. Scott
    Andreas Engert
    Christian Steidl
    Michael Altenbuchinger
    Andreas Rosenwald
    Leukemia, 2021, 35 : 3589 - 3593
12345